Conference Highlights:
Kaletra Conference News. Abstracts and Posters
from the

A WEEK-IN-REVIEW FEATURED REPORT
CONFERENCE PDF POSTER
New Tablet Formulation of Lopinavir/Ritonavir  Bioequivalent to the Capsule at a Dose of 800/200
T. Zhu, Y. Chiu, T. Doan, et al
Conference Poster

A WEEK-IN-REVIEW FEATURED REPORT CONFERENCE PDF POSTER Differences in Treatment Compliance Between Lopinavir/ritonavir (LPV/r) Given Once (QD) Versus Twice (BID) Daily Do Not Affect Virologic or Immunologic Outcomes R. Rode, B. Vrijens, K. Niemi , et al Conference Poster

A WEEK-IN-REVIEW FEATURED REPORT CONFERENCE PDF POSTER Comparative Safety and Anti-HIV Activity of a Dual Protease Inhibitor Regimen (Lopinavir/ritonavir+ Saquinavir) versus a Nucleoside-Containing Regimen DW. Cameron, J. Eron, C. Farthing,  et al Conference Poster   Plasma HDL Cholesterol Increases as a Function of Long-Term Exposure to Lopinavir/Ritonavir (LPV/r), in Naive and Pre-Treated HIV-Infected Patients J. MEYNARD, K. LACOMBE , J. POIRIER, et al Conference Abstract   Rapid Emergence of Resistance to Lopinavir in HIV-2 Due to Selection of ProV47A Mutation B. RODES, C. TORO, J. SHELDON, V. JIMENEZ, et al Conference Abstract